Proxibarbital

Proxibarbital
Systematic (IUPAC) name
5-(2-hydroxypropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione
Identifiers
CAS number	2537-29-3
ATC code	N05CA22
PubChem	17336
Chemical data
Formula	C10H14N2O4
Mol. mass	226.229 g/mol
Synonyms	Proxibarbital, Centralgol, Ipronal, 5-Allyl-5-(β-hydroxypropyl)barbituric acid
Pharmacokinetic data
Bioavailability	?
Metabolism	?
Half life	?
Excretion	?
Therapeutic considerations
Pregnancy cat.	?
Legal status
Routes	?

WikiDoc Resources for Proxibarbital
Articles
Most recent articles on Proxibarbital Most cited articles on Proxibarbital Review articles on Proxibarbital Articles on Proxibarbital in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Proxibarbital Images of Proxibarbital Photos of Proxibarbital Podcasts & MP3s on Proxibarbital Videos on Proxibarbital
Evidence Based Medicine
Cochrane Collaboration on Proxibarbital Bandolier on Proxibarbital TRIP on Proxibarbital
Clinical Trials
Ongoing Trials on Proxibarbital at Clinical Trials.gov Trial results on Proxibarbital Clinical Trials on Proxibarbital at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Proxibarbital NICE Guidance on Proxibarbital NHS PRODIGY Guidance FDA on Proxibarbital CDC on Proxibarbital
Books
Books on Proxibarbital
News
Proxibarbital in the news Be alerted to news on Proxibarbital News trends on Proxibarbital
Commentary
Blogs on Proxibarbital
Definitions
Definitions of Proxibarbital
Patient Resources / Community
Patient resources on Proxibarbital Discussion groups on Proxibarbital Patient Handouts on Proxibarbital Directions to Hospitals Treating Proxibarbital Risk calculators and risk factors for Proxibarbital
Healthcare Provider Resources
Symptoms of Proxibarbital Causes & Risk Factors for Proxibarbital Diagnostic studies for Proxibarbital Treatment of Proxibarbital
Continuing Medical Education (CME)
CME Programs on Proxibarbital
International
Proxibarbital en Espanol Proxibarbital en Francais
Business
Proxibarbital in the Marketplace Patents on Proxibarbital
Experimental / Informatics
List of terms related to Proxibarbital

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Proxibarbital (Ipronal) is a barbiturate derivative invented in the 1970s. It has sedative, hypnotic and anticonvulsant properties, and was used in the treatment of migraine headaches in a similar manner to butalbital.

References

Cost Effectiveness of Proxibarbital

| group5 = Clinical Trials Involving Proxibarbital | list5 = Ongoing Trials on Proxibarbital at Clinical Trials.gov • Trial results on Proxibarbital • Clinical Trials on Proxibarbital at Google

| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Proxibarbital | list6 = US National Guidelines Clearinghouse on Proxibarbital • NICE Guidance on Proxibarbital • NHS PRODIGY Guidance • FDA on Proxibarbital • CDC on Proxibarbital

| group7 = Textbook Information on Proxibarbital | list7 = Books and Textbook Information on Proxibarbital

| group8 = Pharmacology Resources on Proxibarbital | list8 = AND (Dose)}} Dosing of Proxibarbital • AND (drug interactions)}} Drug interactions with Proxibarbital • AND (side effects)}} Side effects of Proxibarbital • AND (Allergy)}} Allergic reactions to Proxibarbital • AND (overdose)}} Overdose information on Proxibarbital • AND (carcinogenicity)}} Carcinogenicity information on Proxibarbital • AND (pregnancy)}} Proxibarbital in pregnancy • AND (pharmacokinetics)}} Pharmacokinetics of Proxibarbital •

| group9 = Genetics, Pharmacogenomics, and Proteinomics of Proxibarbital | list9 = AND (pharmacogenomics)}} Genetics of Proxibarbital • AND (pharmacogenomics)}} Pharmacogenomics of Proxibarbital • AND (proteomics)}} Proteomics of Proxibarbital

| group10 = Newstories on Proxibarbital | list10 = Proxibarbital in the news • Be alerted to news on Proxibarbital • News trends on Proxibarbital</small>

| group11 = Commentary on Proxibarbital | list11 = Blogs on Proxibarbital

| group12 = Patient Resources on Proxibarbital | list12 = Patient resources on Proxibarbital • Discussion groups on Proxibarbital • Patient Handouts on Proxibarbital • Directions to Hospitals Treating Proxibarbital • Risk calculators and risk factors for Proxibarbital

| group13 = Healthcare Provider Resources on Proxibarbital | list13 = Symptoms of Proxibarbital • Causes & Risk Factors for Proxibarbital • Diagnostic studies for Proxibarbital • Treatment of Proxibarbital

| group14 = Continuing Medical Education (CME) Programs on Proxibarbital | list14 = CME Programs on Proxibarbital

| group15 = International Resources on Proxibarbital | list15 = Proxibarbital en Espanol • Proxibarbital en Francais

| group16 = Business Resources on Proxibarbital | list16 = Proxibarbital in the Marketplace • Patents on Proxibarbital

| group17 = Informatics Resources on Proxibarbital | list17 = List of terms related to Proxibarbital

}}